Monthly Archives: February 2012

Complete Genomics Announces Formation of Genomic Medicine Advisory Board

MOUNTAIN VIEW, Calif., Feb. 29, 2012 (GLOBE NEWSWIRE) — Complete Genomics Inc Continue reading →

Posted in Cell Medicine | Tagged analysis, chairman, clifford-reid-, complete, complete-genomics, dna, feedback-on-the, information, medical, robert-nussbaum, university | Comments Off

Measuring blood flow to monitor sickle cell disease

Public release date: 29-Feb-2012 [ | E-mail | Share ] Contact: Kimberly Allen allenkc@mit.edu 617-253-2702 Massachusetts Institute of Technology (Cambridge, Mass.) — More than 60 years ago, scientists discovered the underlying cause of sickle cell disease: People with the disorder produce crescent-shaped red blood cells that clog capillaries instead of flowing smoothly, like ordinary, disc-shaped red blood cells do. This can cause severe pain, major organ damage and a significantly shortened lifespan Continue reading →

Posted in Cell Medicine | Tagged a-because-their, a-patient-has, a-simple-blood, computer-, disease, dorothy-wilson, health-sciences, journal, kimberly-allen, medicine, monitoring, researchers, sangeeta-bhatia, sickle, women | Comments Off

International Cellular Medicine Society Grants First Worldwide Accreditation to Tijuana Clinical Trial

Regenerative Medicine Institute, Mexico has been granted full accreditation for its clinical stem cell trials Portland, Oregon (PRWEB) February 29, 2012 We are pleased that RMI undertook this process, says David Audley, executive director of the ICMS. The clinic understood that patient safety can only be assured through strict evaluation and rigorous oversight Continue reading →

Posted in Cell Medicine | Tagged accreditation, based-medicine-, david-audley, guidelines, portland, practice, transparency, treatment, under-the-icms | Comments Off

Cryo-Cell Reports Financial Results for Fiscal 2011

OLDSMAR, Fla., Feb. 29, 2012 /PRNewswire/ –Cryo-Cell International, Inc Continue reading →

Posted in Cell Medicine | Tagged aruba, clients, cryo-, development, employment, financial, goals, licensees, manufacturing, markets, mercedes, november, pakistan, processing | Comments Off

Adult stem cell coatings for regenerative medicine – Review article

close select a state: Please choose Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming Current state : Not selected. Continue reading →

Posted in Cell Medicine | Tagged california, carolina, florida, hawaii, island, kansas-kentucky, louisiana-maine, mexico, north-carolina, pennsylvania, tennessee-texas, texas, virginia | Comments Off

Advanced Cell Technology To Announce 2011 Fourth Quarter and Year-End Results on March 1st

MARLBOROUGH, Mass.–(BUSINESS WIRE)– Advanced Cell Technology, Inc. (ACT; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that it will release 2011 fourth quarter and year-end results on Thursday, March 1st after the market closes. The Company will hold a conference call on Friday, March 2nd at 9:00 am eastern time to discuss the results and provide an update on clinical activities. Continue reading →

Posted in Cell Medicine | Tagged advanced-cell, based-on-the, beliefs, development, field, intellectual, news, private, reference, statements, statements-are, technology, time, words | Comments Off

Nuvilex Reveals Goldman Small Cap Research Cites Groundbreaking Cancer Therapy in Updating Buy Recommendation

SILVER SPRING, Md.–(BUSINESS WIRE)– Nuvilex, Inc. (OTCQB:NVLX), an emerging biotechnology provider of cell and gene therapy solutions, announced today Goldman Small Cap Research has reissued its buy recommendation on Nuvilex with a short term price target of $0.50 per share Continue reading →

Posted in Cell Therapy | Tagged a-short-term, austria-, cell-, following, goldman-report, nuvilex-chief, pancreatic, progress-on-the, respective, value | Comments Off

Stem-cell therapy takes off in Texas

Celltex hosts the largest stem-cell bank in the United States. TYLER RUDICK With Texas pouring millions of dollars into developing adult stem-cell treatments, doctors there are already injecting paying customers with unproven preparations, supplied by an ambitious new company Continue reading →

Posted in Stem Cell Treatment | Tagged a-few-months, a-woman-named, celltex, jamshid-lotfi, japan, jennifer-novak, lotfi, nature, photo, texas, united-states | Comments Off

Cryo-Save Carries on its Stem Cell Education Program in Bulgaria

ZUTPHEN, The Netherlands, February 29, 2012 /PRNewswire/ — Cryo-Save Bulgaria participated in the 5th National Conference of Obstetricians & Gynecologists from the Out-patient Setting, held on February 24-26 in Plovdiv, Bulgaria. After the recent initiatives in Italy, Serbia and Bosnia, Cryo-Save Bulgaria joins Cryo-Saves official training plans and reaffirms the efforts of the company to put together its educational program about stem cells therapies and current applications. Cryo-Save Bulgaria gave a presentation about why the stem cells from the umbilical cord blood should be donated or saved, and not wasted. Continue reading →

Posted in Stem Cell Advances | Tagged ambulatory, belgium, bulgaria, chairman, continents, france, gynecologists, india, obstetricians, public-health | Comments Off

Irving Leads Research Co. Animal Cell Therapies

VOL. 127 | NO. Continue reading →

Posted in Pet Stem Cell Therapy | Tagged a-good-friend, boston, cardiovascular, cell-treatments, chief-executive, director-on-the, education, excellent-fit-, lance-murphey, medical-device, systems-inc-, therapies--, therapies-inc-, university | Comments Off